Universal Beteiligungs und Servicegesellschaft mbH Has $62.59 Million Stock Holdings in CVS Health Corporation $CVS

Universal Beteiligungs und Servicegesellschaft mbH lifted its stake in shares of CVS Health Corporation (NYSE:CVS) by 2.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 830,232 shares of the pharmacy operator’s stock after acquiring an additional 20,082 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in CVS Health were worth $62,591,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the stock. Harbor Capital Advisors Inc. raised its holdings in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the last quarter. Avion Wealth increased its position in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 189 shares during the period. Corundum Trust Company INC bought a new position in CVS Health during the third quarter worth $29,000. Harbor Asset Planning Inc. acquired a new position in CVS Health in the second quarter valued at $30,000. Finally, Front Row Advisors LLC boosted its position in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 371 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CVS has been the subject of several research analyst reports. Wells Fargo & Company lowered their price objective on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday, November 13th. Truist Financial set a $100.00 target price on CVS Health in a report on Wednesday, December 10th. Sanford C. Bernstein restated a “market perform” rating and set a $91.00 price target on shares of CVS Health in a report on Tuesday, January 6th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. Finally, Argus boosted their target price on shares of CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.86.

CVS Health Price Performance

Shares of NYSE:CVS opened at $81.49 on Thursday. CVS Health Corporation has a twelve month low of $52.34 and a twelve month high of $85.15. The stock’s 50 day moving average is $78.88 and its 200-day moving average is $74.56. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $103.44 billion, a price-to-earnings ratio of 214.44, a PEG ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter in the previous year, the business posted $1.09 EPS. CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.